ATP Director Dr. Tim Harris joined SAIC-Frederick, Inc., in January 2007. Dr. Harris has many years of experience in RNA research, including several years on mRNA and Picornaviruses. He also brings a wealth of industry as well as research experience to the program, as former President and CEO of Novasite Pharmaceuticals and Founder CEO of Structural GenomiX. He was also the Vice President of R&D at Sequana and earlier in his career was Director of Biotechnology for Glaxo Research Group and Group Leader at Celltech Ltd. Dr. Harris is very open to any questions or other inquiries about the Program and can be reached at harristjr@mail.nih.gov or 301-846-1144.

The other members of the ATP management team (in addition to the Program's individual laboratory directors) are Jeffrey Lake (operations) and Bruce Crise (business development). Both Jeffrey and Bruce are available to answer any questions you might have about the program and can be reached at lakejeff@mail.nih.gov, 301-846-5758 and criseb@ncifcrf.gov, 301-846-5739, respectively.

Participating Laboratories

Lists the ten ATP facilities, brief summaries of their expertise, and laboratory home page links.

Available Technologies/Expertise

Lists ATP technologies and expertise alphabetically and by laboratory.

Available Services

Lists ATP research support prices alphabetically and by laboratory. Prices to non-NCI scientists will differ.

TRG Update Newsletter

ATP is part of the Technology and Research Group (TRG), which comprises five directorates that employ advanced biomedical technologies in support of the mission of the National Cancer Institute. TRG now has a quarterly newsletter providing news and events from each of the directorates. The current issue is now available.